Inogen (INGN) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | -17.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.26% |
| Dec 31, 2025 | -16.39% |
| Sep 30, 2025 | -20.43% |
| Jun 30, 2025 | -8.77% |
| Mar 31, 2025 | -6.95% |
| Dec 31, 2024 | -10.93% |
| Sep 30, 2024 | -19.18% |
| Jun 30, 2024 | -17.57% |
| Mar 31, 2024 | -1.34% |
| Dec 31, 2023 | -35.82% |
| Sep 30, 2023 | -4.62% |
| Jun 30, 2023 | 36.71% |
| Mar 31, 2023 | 7.33% |
| Dec 31, 2022 | 12.10% |
| Sep 30, 2022 | 30.77% |
| Jun 30, 2022 | 19.29% |
| Mar 31, 2022 | -9.42% |
| Dec 31, 2021 | -7.29% |
| Sep 30, 2021 | -4.60% |
| Jun 30, 2021 | 0.55% |
| Mar 31, 2021 | -9.38% |
| Dec 31, 2020 | -11.42% |
| Sep 30, 2020 | -6.69% |
| Jun 30, 2020 | -16.78% |
| Mar 31, 2020 | 13.76% |
| Dec 31, 2019 | 5.18% |
| Sep 30, 2019 | -7.12% |
| Jun 30, 2019 | -6.21% |
| Mar 31, 2019 | 40.43% |
| Dec 31, 2018 | 32.35% |
| Sep 30, 2018 | 46.83% |
| Jun 30, 2018 | 57.92% |
| Mar 31, 2018 | 86.88% |
| Dec 31, 2017 | 109.36% |
| Sep 30, 2017 | 76.74% |
| Jun 30, 2017 | 60.60% |
| Mar 31, 2017 | 143.49% |
| Dec 31, 2016 | 109.35% |
| Sep 30, 2016 | 210.88% |
| Jun 30, 2016 | 330.62% |
| Mar 31, 2016 | 277.88% |